Insider · CIK 0001865826
David C. Hanley
Files at NUVB (Nuvation Bio Inc.). First filing Nov 21, 2025, latest Nov 21, 2025.
David C. Hanley files SEC Form 4 as officer at NUVB (Nuvation Bio Inc.). Since Nov 21, 2025, David C. Hanley has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.4M, the latest filed on Nov 21, 2025.
A track record needs three past buys with six months of prices behind them; David C. Hanley has 0, so none is measured yet.
The newest scored trade: sold $1.4M of NUVB on Nov 19, 2025, filed Nov 21, 2025, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUVB: Nuvation Bio Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Nuvation Bio Inc. | $1.4M 200,000 shares | -89% | +331% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 19, 2025 | NUVB NUVATION BIO INC. | 200,000 0.06% of outstanding | $1.4M | Nov 19, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +748,130 | $0.00 | $0 | 748,130 | Mar 3, 2026 |
| Nov 19, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock | +200,000 | $1.87 | $374k | 224,000 | Nov 21, 2025 |
| Nov 19, 2025 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock | -200,000 | $7.14 | $1.4M | 24,000 | Nov 21, 2025 |
| Nov 19, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative | -200,000 | $0.00 | $0 | 300,000 | Nov 21, 2025 |
| Feb 28, 2025 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Mar 4, 2025 |
Questions about David C. Hanley
Answered from the filings on this page, as of the latest one.
Is David C. Hanley buying or selling?
In the last 12 months David C. Hanley reported 0 open-market buys worth $0 and 1 open-market sell worth $1.4M on SEC Form 4; the latest was sold $1.4M of NUVB on Nov 19, 2025. Grants, option exercises and tax withholding are not counted.
How did David C. Hanley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David C. Hanley has 0.
Where does David C. Hanley file Form 4?
David C. Hanley has filed Form 4 at NUVB (Nuvation Bio Inc.) as CHIEF TECHNICAL OPERATIONS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.